| Marc E Hines, MD | |
|
1313 N Court St, Suite B, Ottumwa, IA 52501-1911 | |
| (641) 682-4978 | |
| (641) 682-0722 |
| Full Name | Marc E Hines |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 45 Years |
| Location | 1313 N Court St, Ottumwa, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265434674 | NPI | - | NPPES |
| 3205153 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 23551 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercyone Waterloo Medical Center | Waterloo, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Covenant Medical Center Inc | 0244148732 | 211 |
News Archive
A new study indicates that adolescent females with acute leukemia have low rates of pregnancy screening prior to receiving chemotherapy that can cause birth defects.
Millar Instruments, Inc. developer and manufacturer of Mikro-Tip® pressure transducer catheters and pressure-volume (P-V) systems and Harvard Apparatus, manufacturer of specialty life science equipment, today announced a new distribution partnership.
Quanterix Corporation, a company dedicated to digitizing biomarker analysis with the goal of advancing the science of precision health, today announced it will be expanding its single molecule array, or Simoa, technology platform portfolio to include the new Quanterix SR-Plex benchtop instrument.
Human Genome Sciences, Inc. today announced the presentation of additional results from BLISS-76, one of two pivotal Phase 3 trials of BENLYSTA (belimumab) in seropositive patients with systemic lupus erythematosus. The additional data will be presented in Vancouver at the 9th International Congress on Systemic Lupus Erythematosus on Friday and Saturday, June 25-26.
› Verified 1 days ago
| Entity Name | Covenant Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548288160 PECOS PAC ID: 0244148732 Enrollment ID: O20031111000534 |
News Archive
A new study indicates that adolescent females with acute leukemia have low rates of pregnancy screening prior to receiving chemotherapy that can cause birth defects.
Millar Instruments, Inc. developer and manufacturer of Mikro-Tip® pressure transducer catheters and pressure-volume (P-V) systems and Harvard Apparatus, manufacturer of specialty life science equipment, today announced a new distribution partnership.
Quanterix Corporation, a company dedicated to digitizing biomarker analysis with the goal of advancing the science of precision health, today announced it will be expanding its single molecule array, or Simoa, technology platform portfolio to include the new Quanterix SR-Plex benchtop instrument.
Human Genome Sciences, Inc. today announced the presentation of additional results from BLISS-76, one of two pivotal Phase 3 trials of BENLYSTA (belimumab) in seropositive patients with systemic lupus erythematosus. The additional data will be presented in Vancouver at the 9th International Congress on Systemic Lupus Erythematosus on Friday and Saturday, June 25-26.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Marc E Hines, MD 1313 N Court St, Suite B, Ottumwa, IA 52501-1911 Ph: (641) 682-4978 | Marc E Hines, MD 1313 N Court St, Suite B, Ottumwa, IA 52501-1911 Ph: (641) 682-4978 |
News Archive
A new study indicates that adolescent females with acute leukemia have low rates of pregnancy screening prior to receiving chemotherapy that can cause birth defects.
Millar Instruments, Inc. developer and manufacturer of Mikro-Tip® pressure transducer catheters and pressure-volume (P-V) systems and Harvard Apparatus, manufacturer of specialty life science equipment, today announced a new distribution partnership.
Quanterix Corporation, a company dedicated to digitizing biomarker analysis with the goal of advancing the science of precision health, today announced it will be expanding its single molecule array, or Simoa, technology platform portfolio to include the new Quanterix SR-Plex benchtop instrument.
Human Genome Sciences, Inc. today announced the presentation of additional results from BLISS-76, one of two pivotal Phase 3 trials of BENLYSTA (belimumab) in seropositive patients with systemic lupus erythematosus. The additional data will be presented in Vancouver at the 9th International Congress on Systemic Lupus Erythematosus on Friday and Saturday, June 25-26.
› Verified 1 days ago
Jimmy R. Mascaro, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 312 E Alta Vista Ave, Ottumwa, IA 52501 Phone: 641-683-4454 Fax: 641-683-4450 | |
Quentin Stokes Dickins Jr., M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1112 N Van Buren Ave, Suite 3, Ottumwa, IA 52501 Phone: 641-682-8302 Fax: 641-682-6534 | |
Dr. Taniya Pradhan, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1001 Pennsylvania Ave, Ottumwa, IA 52501 Phone: 641-684-2300 | |
Dr. Cyndi J Mccormick, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 201 S Market St, Ottumwa, IA 52501 Phone: 641-683-5773 Fax: 641-226-5759 | |
Dr. Joseph Hime Iii, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1001 Pennsylvania Ave, Ottumwa, IA 52501 Phone: 641-682-7511 | |
Dr. Ronald Ray Berges, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1112 N Van Buren Ave, Ottumwa, IA 52501 Phone: 641-684-7744 |